FIELD: biochemistry.
SUBSTANCE: described is monoclonal antibody which specifically binds to lipoarabinomannan of acid-fast bacilli, particularly with lipoarabinomannan of tuberculosis bacilli. Described antibody is monoclonal antibody containing variable heavy and light chain variable region, connected through linker. Variable heavy chain contains CDR1-CDR3 shown in (a)-(c), and light chain contains CDR1-CDR3 shown in (d)-(f):
(a) heavy chain CDR1, consisting of amino acid sequence SEQ ID No:1,
(b) heavy chain CDR2 consisting of amino acid sequence SEQ ID No:2,
(c) heavy chain CDR3 consisting of amino acid sequence SEQ ID No:3,
(d) light chain CDR1, consisting of amino acid sequence SEQ ID No:4,
(e) light chain CDR2 consisting of amino acid sequence SEQ ID No:5, and
(f) light chain CDR3 consisting of amino acid sequence SEQ ID No:6. Invention also describes reagent kit and device containing described antibody.
EFFECT: invention extends range of products for detecting of mycobacteria.
18 cl, 19 dwg, 5 tbl, 12 ex
Title | Year | Author | Number |
---|---|---|---|
NOVEL MONOCLONAL ANTIBODIES TO LAM AND PIM6/LAM FOR DIAGNOSING AND TREATING INFECTIONS CAUSED BY MYCOBACTERIUM TUBERCULOSIS | 2017 |
|
RU2732502C2 |
DIAGNOSTIC TECHNIQUE FOR MYCOBACTERIUM TUBERCULOSIS | 2015 |
|
RU2594063C1 |
ANTI-c-Met ANTIBODY | 2009 |
|
RU2560257C2 |
BIOANALYSIS AND PEPTIDES USED IN SAID BIOANALYSIS | 2006 |
|
RU2439080C2 |
HUMANISED ANTIBODIES AGAINST TNFα | 2012 |
|
RU2549700C1 |
IL2 ANTIBODIES | 2006 |
|
RU2425054C2 |
ANTI-ROBO4 ANTIBODY | 2013 |
|
RU2682451C2 |
NEW ANTIBODY TO c-Met | 2011 |
|
RU2607377C2 |
CD43 ANTIBODIES AND USE THEREOF FOR TREATING CANCER | 2016 |
|
RU2694903C1 |
ANTIBODIES TO CD70 | 2012 |
|
RU2604196C2 |
Authors
Dates
2016-06-27—Published
2013-02-28—Filed